# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Roald Amundsen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX003-SYN
- Date: 2026-02-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ingrid Solheim-Achebe, MD
- Calendar frame: modern shifted

## What we are working on

- The pain and clumsiness in his fingers in the cold make him fear he can no longer work in the Arctic **S**
- He does not want any medicine that makes him drowsy, because he drives and flies **S**

## Your goals

- Average finger pain at or below 3 of 10, with fewer cold attacks, by four months. Target: 2026-06-09. Recorded outcome: Average pain 2 of 10 on duloxetine 60 mg; cold attacks shorter and less frequent. **S**
- Able to handle buttons, keys and a pen outdoors in the cold with protective gloves. Target: 2026-05-05. Recorded outcome: Managing with liner and heated gloves and hand warmers. **S**
- Any medicine used causes no daytime drowsiness that affects driving or flying. Target: 2026-06-09. Recorded outcome: No drowsiness on capsaicin cream or duloxetine. **S**

## What we agreed to do

- Neurology consultation in two weeks with nerve conduction studies to confirm or exclude a late post-frostbite neuropathy, entrapment, or another polyneuropathy, and to advise on treatment that does not cause drowsiness. Guideline: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024) **S**
- Cold protection and hand care: liner gloves under mittens, heated gloves and hand warmers outdoors, warming the hands before fine work, no cold-water hand washing, and checking the fingers for skin damage. Guideline: Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024) **S**
- Blood tests for other causes of neuropathy: glucose and HbA1c, vitamin B12, TSH, kidney function, liver enzyme and hemoglobin; PHQ-9 for mood with chronic pain. Guideline: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020); Depression and Suicide Risk in Adults: Screening (2023) **S**
- Capsaicin 0.075% cream to the painful fingers four times a day for localized neuropathic pain, because he wishes to avoid oral treatment, with review in four weeks. Guideline: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020) **S**
- Duloxetine 30 mg daily for a week, then 60 mg daily, for neuropathic pain not controlled by capsaicin cream, with review of pain, adverse effects, sleep, mood and blood pressure, a sodium check, no tramadol, and no abrupt stopping. Guideline: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020) **S**

## Follow-up

- 2026-02-10: New patient visit for cold-induced burning pain and numbness in the fingers of both hands: history, examination, blood tests for other causes of neuropathy, mood screening, cold protection, and a neurology referral **S**
- 2026-02-24: Two-week follow-up and neurology consultation with nerve conduction studies **S**
- 2026-03-24: Six-week review: finger pain on capsaicin cream, starting duloxetine **S**
- 2026-04-07: Periodic adult preventive visit **S**
- 2026-05-05: Twelve-week review: finger pain, mood, blood pressure and sodium on duloxetine **S**
- 2026-06-09: Seventeen-week review: finger pain, the ankle sprain, and the risks of an Arctic air search flight **S**

This teaching document does not replace care from a qualified clinician.
